Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
7.60
-0.08 (-1.04%)
Oct 13, 2025, 4:00 PM EDT - Market closed
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $247.16 million as of October 13, 2025. Its market cap has increased by 174.64% in one year.
Market Cap
247.16M
Enterprise Value
111.85M
1-Year Change
174.64%
Ranking
Category
Stock Price
$7.60
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $247.16M, a decrease of -30.34%. That is a compound annual growth rate of -14.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2025 | 247.16M | 70.60% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
| Jul 14, 2023 | 354.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |